Cardiovascular Systems Inc 4

4 · Cardiovascular Systems Inc · Filed Nov 1, 2013

Form 4

Period: 2013-10-30

Chief Administrative Officer

Transactions

Exercise/Conversion
Common Stock
2013-10-31$12.15/sh+23,620$286,983→ 155,986 total
Sale
Common Stock
2013-10-31$30.35/sh−34,619$1,050,804→ 132,366 total
Exercise/Conversion
Stock Option (right to buy)
2013-10-31−10,999→ 0 total
Exercise: $8.75Exp: 2019-03-02→ Common Stock (10,999 underlying)
Exercise/Conversion
Common Stock
2013-10-31$8.75/sh+10,999$96,241→ 166,985 total
Exercise/Conversion
Stock Option (right to buy)
2013-10-31−23,620→ 0 total
Exercise: $12.15Exp: 2017-12-11→ Common Stock (23,620 underlying)
Exercise/Conversion
Common Stock
2013-10-30$12.15/sh+200$2,430→ 132,566 total
Sale
Common Stock
2013-10-30$30.00/sh−200$6,000→ 132,366 total
Exercise/Conversion
Stock Option (right to buy)
2013-10-30−200→ 23,620 total
Exercise: $12.15Exp: 2017-12-11→ Common Stock (200 underlying)

Footnotes (3)

[F1]The shares were sold pursuant to a Rule 10b5-1 trading plan.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.83 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]Fully exercisable.

Documents

1 file